Tender For bid to ras corrigendum : supply of erythropoietin recombinant human 5000 iu by 0 point 5 ml inj , insulin premixed biphasic human 50 percent human neutral 50 percent human isophane insulin 10 ml inj , insulin lispro biphasic 50 percent 50 percent insulin lispro and 50 percent insuline lispro protamine suspension 100iu by ml 3ml cartridge , insulin glulisine injection cartridge 100 iu by ml 03 ml , biphasic isophane insulin 50 percent soluble insuline and 50 percent isophan insulin suspension 100 iu by ml 3 ml cartridge , biphasic isophane insulin 30 percent soluble insuline and 70 percent isophan insulin suspension 100 iu by ml 3 ml cartridge , inj leuprolide pfs by vial of 11 point 25 mg
Tender For re e-tender for procurement of drug items under table-a, for two years from the date of aoc - atazanavir 300mg + ritonavir 100 mg tabs, cephalexin oral suspension 250mg/5ml, conjugated estrogen 0.625mg tab, conjugated estrogen vaginal cream, estriol cream 0.1% w/w, dabigatran etexilate mesylate cap. 110 mg, delamanid 50mg tab., desmopressin nasal spray 100 mcg/ml, dicylomine hydrochloride 10 mg tab., fosphenytoin inj 50 mg/ml , 10 ml, glycopyrrolate inj.u.s.p. 0.2 mg / 1 ml amp., human recombinant growth hormone inj. iu [note: rate should be quoted per iu ], hydralazine inj 20 mg/ml, ibandronate 150 mg tab, ibandronate 50mg tab, imipramine tab. ip 25 mg, isoprenaline inj 2mg/1ml, leuprolide acetate inj.(3.75mg), norethistrone tab ip 5 mg, primaquine tab. i.p. 2.5 mg., primaquine tab.i.p. 7.5 mg., propofol inj.b.p. 1 %, w/v in 10 ml vial., rabies vaccines i.p. human use (cell culture derived) with minimum potency of 2.5 i.u/ vial for both id route & im route (one im dose or 5 id dose )+ diluents 0.5ml, ringers lactate inj.- glass bottle 500ml, sildenafil inj 10mg, sildenafil syrup 10mg/1 ml, snake anti venom serum i.p.liquid (10ml) neutralizing venoms of cobra, common krait, russells viper, saw scaled viper., sodium chloride inj 0.9% (normal or isotonic saline) glass bottle, sulphamethoxazole 100mg + trimethoprim 20mg tablet i.p, triptorelin 11.25 mg la inj, bupropion hydrochloride 150mg tab., carboplatin inj. 450 mg./ vial, haloperidol tab. 0.25mg, insulin (human pre mixed ) soluble & nph combination (30 : 70) or (25:75)/ i.u. -in vial(maximum pack size allowed 10ml /vial), insulin soluble inj. i.p.40 i.u. / ml in 10 ml vial ., nortriptyline 25mg tab., zinc sulphate 20 mg. (dispersable) tab., important note: 1. all prospective bidders are requested to quote the rate in boq as per accounting unit & item specification as mentioned in the table-a. wrong quoting of the rate in boq will be dealt with as per penal provisions of the t&c of the tender.2. tendered quantity is just a tentative quantity and should not be treated as final. it may increase or decrease, as per need of the state. keeping this in mind, the supplier is not allowed to seek termination of the rate contract after finishing supply of tendered quantity.3. quality of the product supplied, may be ascertained by testing / physical examination by the experts at any stage of the tender period.4. the prospective bidders of the said tender are requested to make a declaration in affidavit under annexure vi(b) in case of sole manufacturer/importer (i.e. proprietary in nature).5. if the item(s) under sole manufacturer / importer is (are) proprietary in nature, quarterly intimation is solicited from the approved bidders positively regarding the status of their item(s) proprietary in nature, otherwise their item(s) will be blocked in the smis.6. in case of tie bid, decision will be taken by the tia as per g.o. no. 2320-f(y), dated 07.06.2022 issued from finance department audit branch (group t).
Tender For corrigendum : supply of drugs and pharmaceutals - d cfa re 34 lidocainelignocaine hcl 2 with adrenaline epinephrine 180000 1 dot 8 ml cartridge , d cfa re 34 insulin premixed biphasic 40 iu per ml 30 human neutral plus 70 human isophane , d cfa re 34 atropine sulphate oint 1 tube of 3gm , d cfa re 34 phenobarbitone syp 20 mg5 ml bott of 60 ml , d cfa re 34 chlorpromazine im and iv 25 mgml 2ml inj , d cfa re 34 tianeptine 12 dot 5 mg tab , d cfa re 34 formoterol 6 mcg glycopyrronium 25 mcg dry powder inhaler , d cfa re 34 salbutamol sulphate 500 mcgml 1ml inj , d cfa re 34 formoterol fumarate 12 mcg dry powder , d cfa re 34 budesonide 200 mcg dry powder , d cfa re 34 codeine phosphate 10 mg chlorpheniramine maleate 4 mg per 5 ml syp bottle of 100 ml , d cfa re 34 hydroxy ethyl starch 6 soln bott of 500 ml , d cfa re 34 desmopressin nasal spray 0 dot 1 mgml in vial of 2 dot 5 ml , d cfa re 34 vit d3 cholecalciferol sachet 60000 iu per 1gm sachet , d cfa re 34 vitamin-c 500mg inj , d cfa re 34 bambuterol 10mg tab , d cfa re 34 ethionamide 250 mg tab , d cfa re 34 fluticasone propionate lotion 0 dot 05 bott of 10 ml , d cfa re 34 dorepenem monohydrate 500 mg powder for injection , d cfa re 34 cefuroxime 750 mgvial inj , d cfa re 34 sulphamethoxazole 200 mg and trimethoprim 40 mg per 5 ml bottle of 5060 ml suspension , d cfa re 34 vitamin b complex with a minimum concentration of vit b15mg vit b63mg vit b125mcg therapeutic tabcap , d cfa re 34 dextrose monohydrate for oral use in pack of 100 gm with or without vitamins and minerals , d cfa re 34 tetanus human immunoglobulin ) /bid number : gem/2026/b/7548705 * /dated: 16-05-2026 & & / bid document 1 / 25
Tender For supply of inj. human insulin 30:70 (30% as soluble insulin & 70% as isophane insulin)100 iu/ ml with provision of atleast one free pen and atleast twenty free needles per 20 cartridges.3ml cartidge ]